Citations 2
Comparison of health care costs and resource utilization for commonly used proteasome inhibitor–immunomodulatory drug-based triplet regimens for the management of patients with relapsed/refractory multiple myeloma in the United States
Sanchez, Larysa , Cheng, Mu, Cherepanov, Dasha , DerSarkissian, Maral , Stull, Dawn Marie, Dabora, Jonathan, Young, Melanie , Noga, Stephen J. , Pi, Selina , Banatwala, Azeem , Duh, Mei Sheng , Chari, Ajai , Chari, Ajai , Huang, Fei, Zhang, Melody , Ailawadhi, Sikander
Journal of Managed Care & Specialty Pharmacy | September 30, 2023 | Volume: 29 | Issue: 11 | Pages: 1205-1218
Comparative Effectiveness of Lenalidomide/Dexamethasone-Based Triplet Regimens for Treatment of Relapsed and/or Refractory Multiple Myeloma in Subgroups Defined By Cytogenetic Risk
Sanchez, Larysa , Cheng, Mu, Cherepanov, Dasha , DerSarkissian, Maral , Stull, Dawn Marie, Hilts, Annalise, Duh, Mei Sheng , Huang, Fei, Chun, Justin, Ailawadhi, Sikander
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4308-4309